2015 annual financial data
CytomX Therapeutics, Inc. 2015 Operating margin
CytomX Therapeutics, Inc. 2015 operating margin with verified reported values.
Direct answer
Operating margin was -430.54%.
Operating income was -33,203,000 USD and net income was -35,374,000 USD.
Operating cash flow was -27,415,000 USD.
Get free CytomX Therapeutics, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 7,712,000 USD
- Operating income
- -33,203,000 USD
- Net income
- -35,374,000 USD
- Operating cash flow
- -27,415,000 USD